Physician profile
Emma Brown
NPI 1457173999
$2,437.76
in general payments reported to CMS, 2019-2025
15 companies · $2,248 in 2025
The $2,248 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $190 · 2025: $2,248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,338 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,337.77 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,328.52 | 2024-2025 | |
| Janssen Biotech, INC. | $326.89 | 2024-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $231.84 | 2025 | |
| Radius Health, INC. | $103.58 | 2024-2025 | Tymlos |
| Pfizer INC. | $93.47 | 2025 | |
| Aurinia Pharma U.S., INC. | $75.25 | 2024-2025 | Lupkynis |
| E.R. Squibb & Sons, L.L.C. | $62.44 | 2025 | Orencia |
| Amgen INC. | $43.91 | 2025 | Otezla |
| Glaxosmithkline, LLC. | $39.72 | 2025 | Benlysta |
| Ani Pharmaceuticals, INC. | $31.16 | 2025 | Purified Cortrophin Gel |
| Genzyme Corporation | $25.19 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $23.59 | 2025 | Saphnelo |
| Alexion Pharmaceuticals, INC. | $19.85 | 2024 | Strensiq |
| Invivyd INC | $17.16 | 2025 | Pemgarda |
| Genentech USA, INC. | $15.19 | 2025 | Gazyva |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emma Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.